|
Real-time Estimate
Cboe BZX
21:00:58 03/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 91.00 USD | +1.46% |
|
+0.49% | +35.19% |
| 08-24 | Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing | MT |
| 08-13 | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
Chart: Technical Analysis
CBOEUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DXCM | Delayed | |
CBOE
| DXCM | Real-time | |
Mexican S.E.
| DXCM * | End-of-day quote | |
London S.E.
| 0A4M | Delayed | |
Börse Stuttgart
| DC4 | Delayed | |
Boerse Muenchen
| DC4 | Real-time | |
Tradegate
| DC4 | Real-time | |
Deutsche Boerse AG
| DC4 | Delayed | |
Xetra
| DC4 | Delayed | |
Wiener Boerse
| DXCM | End-of-day quote | |
Borsa Italiana
| 1DXCM | End-of-day quote | |
Swiss Exchange
| DXCM | Delayed | |
Swiss Exchange
| DXCM | Delayed | |
Sao Paulo
| D1EX34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 92.34 | 92.34 | 92.34 |
| Spread/Res. | -2.83% | -2.83% | -2.83% |
| Spread/Supp. | +8.55% | +27.31% | +25.42% |
| Support | 82.66 | 70.48 | 71.54 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions

















